OSCR · Oscar Health, Inc.
Price
Snapshot
50 fields · last close| Market Cap | $10.86B |
| P/E | 19.72 |
| Float | 261.4M |
| Beta | 2.58 |
| Volatility 30D | 50.9% |
| Exchange | NYSE |
| Sector | Insurance |
| Cap tier | Large cap |
| Macro sensitivity | Very High |
| Clavix score | 62.7 |
| Price | 34.41 |
| Change | −2.22% |
| Prev Close | 35.19 |
| Open | 35.63 |
| Day Low | 33.24 |
| Day High | 36.16 |
| Avg Vol | 4 |
| Avg $ Vol | $143.5M |
| 52W High | 35.19 |
| 52W Low | 10.69 |
| 52W Pos | 96.8% |
| From High | −2.22% |
| From Low | +221.89% |
| Max DD 1Y | −40.25% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +5.78% |
| SMA 50 | +8.24% |
| SMA 200 | +44.31% |
| RSI (14) | 64.2 |
| Vol 90D | 56.1% |
| Vol 1Y | 66.6% |
| 1Y Range | 11–35 |
| Daily bars | 549 |
| Perf Week | +15.45% |
| Perf Month | +8.81% |
| Perf Quarter | +32.59% |
| Perf Half Y | +77.37% |
| Perf Year | +99.26% |
| Perf YTD | +129.86% |
| Prev Day | −2.22% |
| Clavix | C+ |
| Debt / Eq | 0.44 |
| Curr Ratio | 0.95 |
| Int Cover | 56.6× |
| FCF Margin | — |
| Rev Growth | +27.5% |
| Profit | Unprofitable |
| Leverage | Low |
| Sector rank | 30 / 31 |
Clavix risk grade
regraded every trading dayOSCR grades C+, 62.7 of 100. Steadiest on News Sentiment (66), most exposed on Price Stability (46, fragile). 0 of the 4 weighted dimensions sit above the Insurance median. Ranks 30 of 31 in Insurance by Clavix score.
How rough the ride is
| OSCR | Insurance median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 2.58 | 0.47 |
| 30-day realized volatilityannualized, from daily closes | 50.9% | 23.6% |
| Max drawdown, past yearworst peak-to-trough fall | −40.3% | — |
| Typical daily movemedian absolute daily change | 2.21% | — |
| Days beyond ±3%of the last 252 sessions | 94 (37%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| OSCR | Insurance median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 2.58 | 0.47 |
| Macro sensitivityrate, dollar and credit exposure bucket | Very High | Low 77% of 31 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Insurance names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| OSCR | |
|---|---|
| 1 week | +15.5% |
| 1 month | +8.8% |
| Year to date | +129.9% |
| 1 year | +99.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| OSCR | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 19 Sep |
| Average score0 most bearish, 100 most bullish | 65 |
| Bullish · bearisharticles above 60 · below 40 | 22 · 4 |
| Directionarticles whose tone is improving vs worsening | 22 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 31 Insurance names Clavix covers; the tick is the sector median.
Growth
| OSCR | |
|---|---|
| Revenue growthyear over year | +27.5% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Insurance median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openOscar Health reported third-quarter earnings of $0.49 per share, beating the Zacks consensus estimate of a $0.11 loss and improving from a $0.53 loss a year earlier. The article says revenue also exceeded estimates but provides no revenue figures.
Oscar Health is expanding beyond Affordable Care Act (ACA) marketplace insurance through Lucie and CHOICE, adding fee-based offerings. Its shares have risen 116% year to date, but the article does not quantify the new businesses’ revenue or profit.
Oscar Health is expanding beyond Affordable Care Act (ACA) insurance through Lucie and CHOICE, adding fee-based offerings to its growth strategy. Its shares have risen 116% year to date.
After enhanced subsidies for the Affordable Care Act (ACA) health-insurance marketplace expired in 2026, Oscar Health remained in the disrupted market as competitors exited or raised prices, and it reached out to brokers. At its investor day, Oscar outlined expansion into healthcare revenue beyond ACA insurance; its shares were above $34 ahead of the Oct. 22 open, up more than 200% from March lows, and it had forecast $250 million to $450 million in profit from operations for 2026 alongside rapid expected revenue growth.
Oscar Insurance, part of Oscar Health, unveiled its 2027 health insurance lineup in the individual insurance market during the open enrollment period. The article does not provide plan details, pricing, enrollment figures, or expected financial results.
Nearest peers by size
Insurance| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| GL | Globe Life Inc. | A- | $12.43B | 10.41 | 0.45 | Compare |
| ERIE | Erie Indemnity Co | B- | $13.04B | 22.09 | 0.22 | Compare |
| KNSL | Kinsale Capital Group Inc | B | $8.82B | 16.77 | 0.80 | Compare |
| RNR | RenaissanceRe Holdings Ltd. | A- | $14.29B | 5.36 | 0.11 | Compare |
| UNM | Unum Group | A- | $14.43B | 16.61 | 0.23 | Compare |
| AIZ | Assurant Inc | A | $15.22B | 13.73 | 0.52 | Compare |
| AXS | AXIS Capital Holdings Limited | B+ | $7.73B | 6.87 | 0.38 | Compare |
| EG | Everest Group, Ltd. | A- | $15.61B | 7.95 | 0.22 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.